EMA Reviewing Data For Merck’s COVID-19 Treatment

The AP (11/8) reports the European Medicines Agency “on Monday began reviewing Merck’s COVID-19 treatment pill [molnupiravir] so that it can swiftly advise national drug authorities in the 27-nation bloc that want to begin using it before it gets official...